Norfloxacin For Hepatopulmonary Syndrome: A Pilot Study of a Rare Disease
Norfloxacin For Hepatopulmonary Syndrome: A Pilot Study of a Rare Disease Samir Gupta, Masters of Science, 2008 Graduate Department of Health Policy, Management and Evaluation University of Toronto Introduction: Hepatopulmonary Syndrome is a rare disease characterized by abnormal gas-exchange an...
Main Author: | |
---|---|
Other Authors: | |
Format: | Others |
Language: | en_ca |
Published: |
2008
|
Subjects: | |
Online Access: | http://hdl.handle.net/1807/10431 |